Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 199Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Zhejiang Hengkang Pharmaceutical

02 1Jiangsu Nhwa Pharmaceutical

03 1Nanjing Dorra Pharmaceutical Technology Co.,Ltd

04 1Olon S.p.A

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothZhejiang Hengkang Pharm Group is a dynamic pharmaceutical entity, spanning drug research, large-scale production, and global marketing.

Ciprofibrate

About the Company : Established in 2004 and headquartered in Hangzhou, Hengkang established multiple factories, research and sales centers in Zhejiang, Shandong, and Henan. With facilities conforming ...

Established in 2004 and headquartered in Hangzhou, Hengkang established multiple factories, research and sales centers in Zhejiang, Shandong, and Henan. With facilities conforming to global API standards, along with professional R&D and marketing teams, Hengkang’s operations span major pharmaceutical markets such as China, Europe, the CIS region, Japan, and South Korea. Hengkang has established long-term and stable relationships with nearly 70 countries overseas and hundreds of domestic enterprises.
Zhejiang Hengkang Pharmaceutical

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Ciprofibrate

About the Company : Nhwa is specialized in manufacturing APIs and dosages in the field of Central Nervous System. With 40 years of experience and excellent reputation, Nhwa has become the leader of ma...

Nhwa is specialized in manufacturing APIs and dosages in the field of Central Nervous System. With 40 years of experience and excellent reputation, Nhwa has become the leader of manufacturing CNS drugs in China. The 520,000 m2 production base consists of five GMP workshops, R&D center and testing Lab
blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Ciprofibrate

About the Company : Dorrapharma is engaged in R&D, manufacture and market of intermediate, API (Active Pharmaceutical Ingredients) and formulation. We stick to raise the value both for the company and...

Dorrapharma is engaged in R&D, manufacture and market of intermediate, API (Active Pharmaceutical Ingredients) and formulation. We stick to raise the value both for the company and customer, and strive for serving for the society and caring of the others. We devote ourselves completely to the technology innovation and brand build, and make every effort to foster the core competence for the company. We are in a progress of becoming a global leading pharmaceutical server.
blank

04

Olon S.p.A

Italy
2024 ACI Convention
Not Confirmed
arrow

Olon S.p.A

Italy
arrow
2024 ACI Convention
Not Confirmed

Ciprofibrate

About the Company : We produce Active Pharmaceutical Ingredients (APIs) providing integrated full-service capabilities. Olon’s ability to develop and manufacture Active Pharmaceutical Ingredients (...

We produce Active Pharmaceutical Ingredients (APIs) providing integrated full-service capabilities. Olon’s ability to develop and manufacture Active Pharmaceutical Ingredients (APIs) in our network of facilities allows clients full access to integrated services resulting in faster production and delivery timelines, with one of the most extensive track records. We rely on synthetic and biological processes both for generic and contract development and the manufacturing market, in a full cGMPs environment, following ICH Q7 compliance.
blank

Ciprofibrate Manufacturers | Traders | Suppliers

Ciprofibrate Manufacturers, Traders, Suppliers 1
19

We have 4 companies offering Ciprofibrate

Get in contact with the supplier of your choice:

  1. Zhejiang Hengkang Pharmaceutical
  2. Jiangsu Nhwa Pharmaceutical
  3. Nanjing Dorra Pharmaceutical Technology Co.,Ltd
  4. Olon S.p.A